Status:
TERMINATED
Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer
Lead Sponsor:
Texas Tech University Health Sciences Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-99 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if the use of magnetic resonance imaging (MRI) for breast cancer translates into better surgical outcomes. MRIs may help ensure that as little healthy tissue ...
Detailed Description
We propose that the role of preoperative staging-MRI in breast cancer be studied by following the occurrence of negative margins at first surgery and the volume of resection in a randomized prospectiv...
Eligibility Criteria
Inclusion
- Newly diagnosed breast cancer patients
- Breast cancer patients identified as conservation candidates by their surgeons
Exclusion
- Patients with a history of prior breast cancer treatment (recurrence)
- Patients with breast cancer diagnosis during pregnancy (women who could bear children must have a negative pregnancy test before beginning this study)
- Patients with documented sensitivity to gadolinium (contrast agent used during MRI)
- Patients who weigh more than 350 pounds (weight limit on MRI machine)
- Patients who receive neoadjuvant chemotherapy
- Patients with renal insufficiency (serum Cr \> 1.5) due to the danger of nephrogenic systemic sclerosis with the administration of Gadolinium
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT00948285
Start Date
July 1 2009
End Date
December 1 2018
Last Update
November 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Tech University Health Sciences Center School of Medicine
Amarillo, Texas, United States, 79106